Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -11.11% | 142.29 | 0.0% | $1319.96m | |
| AMGN | Amgen, Inc. | -1.77% | 223.69 | 1.4% | $503.68m | |
| NVAX | Novavax, Inc. | -14.92% | 72.02 | 78.2% | $494.42m | |
| BIIB | Biogen, Inc. | -0.54% | 219.33 | 1.8% | $494.09m | |
| GILD | Gilead Sciences, Inc. | -0.61% | 68.09 | 1.0% | $489.01m | |
| BNTX | BioNTech SE | -3.74% | 141.99 | 0.0% | $398.06m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.20% | 607.76 | 2.7% | $393.89m | |
| ILMN | Illumina, Inc. | -4.36% | 350.01 | 3.3% | $362.36m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.68% | 224.24 | 1.9% | $335.21m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -7.93% | 2.44 | 0.7% | $170.56m | |
| EXAS | EXACT Sciences Corp. | -7.20% | 68.70 | 17.9% | $156.51m | |
| ARNA | Arena Pharmaceuticals, Inc. | -0.71% | 89.84 | 13.7% | $130.44m | |
| INCY | Incyte Corp. | -1.23% | 73.87 | 2.4% | $128.58m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -4.00% | 130.96 | 8.2% | $120.01m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -2.55% | 82.49 | 4.2% | $100.55m |
Company Profile
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.